Fragility Re-fractures Prediction Score
ConditionOsteoporosis Risk
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
About this trial
Fragility fractures increase among elderly patients worldwide, representing a global burden in terms of disability and care expenditure.
Osteoporosis is asymptomatic up to the moment in which a first fracture occurs, reason why it is often underdiagnosed. Even after that, further fractures do occurr, as osteoporosis is often untreated. Several programs have been introduced worldwide to prevent secondary fractures among the population at risk (e.g., International Osteoporosis Foundation's Capture the Fracture), and several risk factors are being investigated to generate a predictive score. However, accurate validation is needed to make these scores reliable.
In this retrospective observational study, we aim to validate a predictive score trained on a population of elderly patients with a cohort of patients who underwent hip fracture surgery in a high-volume orthopedic center in the Region of Lombardy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
People who underwent total or partial hip replacement (ICD 9 CM 81.51, 81.52) in five years (2013-2017) at the hospital for a compound fracture of the hip (ICD 9 CM 820, 820.01-820.09).
Disqualifiers
People undergoing the same intervention for other reasons (e.g. pathological fracture, ICD 9 CM 733.14).
Trial population
Patients aged 60 or more, of all sexes.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Hip arthroplasty
Other interventionSurgical treatment of the hip after osteoporosis fracture. The focus of the study is the prediction of further fractures (and therefore further surgical procedures) after the first one.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Age, sex, disease name and body mass index (weight in kg and height in m will be combined to report BMI in kg/m^2)
Patient characteristics and comorbidities associated with a fragility fracture of the hip
Time frame
Baseline: the outcomes are assessed before surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov